Stay Ahead of the Market:
- Discover outperforming stocks and invest smarter with Top Smart Score Stocks
- Filter, analyze, and streamline your search for investment opportunities using Tipranks' Stock Screener
The latest announcement is out from Tong Ren Tang Technologies Co ( (HK:1666) ).
Tong Ren Tang Technologies Co. Ltd. announced a renewal of a continuing connected transaction under a new trademark license agreement. The agreement involves a license fee set at 0.3% of the company’s annual license fee base. This fee is deemed fair and reasonable, supported by market research comparing similar transactions, with fees ranging from 0.12% to 1.5%. The company has implemented internal control procedures to ensure compliance with normal commercial terms and industry standards. The renewal indicates a strategic alignment with market practices and ensures robust internal governance, potentially enhancing stakeholder confidence.
More about Tong Ren Tang Technologies Co
Tong Ren Tang Technologies Co. is a joint stock company incorporated in the People’s Republic of China, operating within the pharmaceutical industry. It focuses on the development and provision of traditional Chinese medicine products.
YTD Price Performance: -3.08%
Technical Sentiment Consensus Rating: Buy
Current Market Cap: $806.6M
Find detailed analytics on 1666 stock on TipRanks’ Stock Analysis page.
